Pramodini Medicare’s initial public offering is currently open for subscription, with the issue seeing a total subscription of 0.96x as of the end of Day 2 trading on 13-08-2026. The QIB category continues to lead the pack, booking 1.81x, while the NII (bHNI) segment stands at 0.6x and NII (sHNI) at 0.37x. The retail category remains at 0x. With the IPO closing on 14-08-2026, investors are closely watching whether momentum will pick up in the final hours to push the issue towards full subscription.

Subscription Status

The subscription data indicates strong institutional interest but tepid response from individual investors. Below is the progression of subscriptions:

Intra-day timeline on 13-08-2026

The QIB segment dominated early in the day, securing nearly double the issue size allocated to them, while retail participation has yet to materialize. The total subscription ticked up slightly to 0.96x by mid-morning.

About the Company

Pramodini Medicare is a diagnostic service provider in India, offering technology-enabled services including radiology, clinical laboratory, and nuclear medicine. Founded in 2000, the company operates through four models: Public Private Partnership, Private Private Partnership, Strategic Partnership with PSUs, and Private Centres. It runs 16 diagnostic centres across 7 states and 14 cities. The company is led by MD Dr. Chalasani Kuldeep Kumar and CEO Dr. Chalasani Kavitha.

Financial Highlights

The company has shown consistent revenue growth over the past three years. Key financial figures are presented below:

Revenue grew from ₹35.23 crores in FY 2024 to ₹62.29 crores in FY 2026. Similarly, total profit increased from ₹6.93 crores to ₹17.38 crores over the same period.

Objects of the Issue

• ₹45.15 crores: Funding capital expenditure for purchase of medical equipments towards existing and proposed diagnostic centres.
• General corporate purposes: Meeting general corporate expenses and unidentified inorganic acquisition opportunities.

Risk Factors

• Dependence on Government PPP Arrangements: 54.19% of revenue is derived from these arrangements; non-renewal or payment delays could impact operations.
• Heavy Concentration on Radiology Services: 97.05% of revenue comes from radiology, exposing the company to equipment and regulatory risks.
• Geographic Revenue Concentration: 61.90% of revenue is derived from Andhra Pradesh, making it vulnerable to regional economic slowdowns.

Key Dates

• IPO Open Date: 12-08-2026
• IPO Close Date: 14-08-2026
• Allotment Date: 17-08-2026
• Listing Date: 19-08-2026

Pramodini Medicare IPO opened for subscription today, marking the beginning of its public offering journey. Investors can now apply for the shares within the specified price band as the company seeks to raise capital through this initial public offering.

Subscription Status

On Day 1, the Pramodini Medicare IPO recorded a total subscription of 0.75 x. Qualified Institutional Buyers (QIBs) showed the highest interest among investor categories, subscribing to 1.81 x of their quota. Non-Institutional Buyers (bHNI) subscribed to 0.26 x, while Non-Institutional Buyers (sHNI) accounted for 0.15 x. Retail investors and Employees category subscriptions were reported at 0 x on the first day.

About the Company

Pramodini Medicare is entering the public markets with an issue size ranging from ₹396000 to ₹500000. The company operates in the healthcare sector, aiming to leverage the capital raised from this IPO for its business operations and growth initiatives. Key financial details and broader operational metrics are outlined in the offer documents filed with regulators.

Offer Details

The IPO is priced with a floor price of ₹110.00000 and a ceiling price of ₹118.00000. The minimum bid quantity required for application is 2400 units. The issue size is structured between a minimum of ₹396000 and a maximum of ₹500000. Investors are advised to check the official allotment portal and exchange websites for further updates on the subscription timeline and listing details.